Skip to main content
. Author manuscript; available in PMC: 2019 May 30.
Published in final edited form as: ACS Catal. 2017 Apr 3;7(5):3190–3198. doi: 10.1021/acscatal.7b00201

Figure 2.

Figure 2

Top, Representative snapshots of the active site of MR in the RS, TS and PS configurations. For clarity, only the isoalloxazine moiety of FMN and nicotinamide moiety of NADH are shown. Below, a schematic of each configuration showing key distances (red in Å) and angles (blue).